Julia A. Haller was appointed as Director at Outlook Therapeutics, Inc..
“appointed Dr. Julia A. Haller to fill the newly created vacancy”
Outlook Therapeutics, Inc. — fact timeline
Source-grounded facts extracted from Outlook Therapeutics, Inc.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Lawrence Kenyon resigned as Chief Financial Officer at Outlook Therapeutics, Inc..
“Mr. Trenary replaces Lawrence Kenyon, who resigned as President and Chief Executive Officer of the Company concurrently with Mr. Trenary’s appointment.”
C. Russell Trenary III was appointed as President and Chief Executive Officer at Outlook Therapeutics, Inc..
“On July 6, 2021, the Board of Directors (the “Board”) of Outlook Therapeutics, Inc. (the “Company”) appointed C. Russell Trenary III as President and Chief Executive Officer of the Company and as a director, effective immediately.”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.